Clinical Care Options (CCO)

Clinical Care Options (CCO) provides interactive online and live CME-certified continuing medical education (CME) programs and proprietary medical education technologies for healthcare professionals. Click here for information on CCO:

We are pleased to share their recent CML modules below:

• Biosimilars in Oncology: Insights into the development and evaluation process
  (Source: Understanding the expanding role of biosimilars in quality cancer care,
  June 2017)
• Ways to help patients accept biosimilars in oncology practice
  (by Sanjiv S. Agarwala, May 2017)
• Chronic Myloid Leukemia: 
  Managing Patients after failure of TKI therapy
  (by Elias Jabbour, October 2016)
• A CML Patient with Elevated BCR-ABL at 3 month:
  To switch or not to switch?
  (by Elias Jabbour, April 2015)
• Providing Optimal Care for Patients with Chronic Myeloid Leukemia
  (by B. Douglas Smith, July 2014)
• Chronic Myeloid Leukemia: Translating State-of-the-Art Practice to Patient care
  (by Jerald Radich & Neil P. Shah, May 2014)